Equities

Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)204.50
  • Today's Change5.50 / 2.76%
  • Shares traded664.88k
  • 1 Year change-0.73%
  • Beta0.9405
Data delayed at least 20 minutes, as of Nov 21 2024 16:41 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Advanced Medical Solutions Group plc is a United Kingdom-based independent developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. Its surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec and Seal-G. It also supplies wound care dressings, such as silver alginates, alginates and foams through its ActivHeal brand, and under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit comprises a multi-product portfolio of advanced wound care dressings and a portfolio of specialist medical bulk materials and multi-layer wound care products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel.

  • Revenue in GBP (TTM)131.11m
  • Net income in GBP11.13m
  • Incorporated1993
  • Employees1.50k
  • Location
    Advanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
  • Phone+44 160 686 3500
  • Fax+44 160 686 3600
  • Websitehttps://www.admedsol.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nyxoah SA4.24m-44.16m229.09m147.00--2.63--54.09-1.72-1.720.1663.040.03660.55692.3034,618.53-38.20-23.73-42.88-25.9861.7562.42-1,042.52-1,469.594.95-45.270.1822--40.99---38.39--100.58--
COLTENE Holding AG213.47m11.03m269.23m1.19k24.453.0115.681.262.062.0639.8916.731.271.386.06198,668.906.5510.4811.7018.7464.9062.685.177.470.861910.180.342179.94-9.133.54-54.05-6.81-7.72-7.79
Guerbet SA688.60m27.30m279.19m2.92k10.560.85983.750.40542.512.5166.4230.820.81280.54935.56282,958.603.031.404.961.8678.5876.023.731.821.163.850.507357.824.30-0.0993158.05-12.615.23-10.07
Stratec SE208.80m8.34m283.20m1.46k33.941.4911.611.360.82360.823620.6118.740.56051.275.32164,609.702.247.072.858.2027.0427.324.009.700.92693.860.401140.81-4.636.88-55.293.30-2.16-7.68
Synektik SA120.10m16.27m283.31m164.0017.417.6715.072.369.929.9273.2522.521.8426.956.41--24.9815.0939.9723.8326.8224.8813.5511.001.4945.180.109--39.8235.9061.3656.0850.89--
IVF Hartmann Holding AG136.68m15.77m313.24m298.0019.862.4814.962.297.357.3563.7258.840.87883.148.52502,947.4010.147.2912.068.9055.2153.2911.548.303.95--0.005852.16-1.792.0934.951.49-14.8326.82
medmix AG428.82m-1.61m327.92m2.70k--0.78686.370.7647-0.05-0.0511.3511.300.47783.405.58180,474.00-0.09962.06-0.12272.4932.5836.38-0.20854.161.062.210.436167.701.991.40-97.41-64.3612.01--
Ion Beam Applications SA388.16m6.54m331.62m1.84k48.874.2520.300.85430.26890.268915.993.090.77212.152.70234,517.101.301.556.014.3234.1935.231.692.380.63723.770.399264.8318.6710.74-250.40---8.06--
CellaVision AB52.84m10.77m361.61m228.0033.586.5726.296.846.306.3030.9132.190.78491.917.263,233,162.0015.9915.3018.4518.2466.9969.0320.3819.982.151,358.860.044110.185.9413.1710.128.0030.458.45
RaySearch Laboratories AB (publ)83.80m12.55m370.29m414.0038.018.2012.414.425.105.1034.0923.650.60235.513.293,005,152.009.021.2913.691.8891.0690.5714.972.551.27108.610.370669.0021.1610.26243.060.7648-1.31--
Advanced Medical Solutions Group plc131.11m11.13m433.39m1.50k39.011.7819.303.310.0510.0510.60111.120.39771.704.91154,244.703.386.543.647.0654.4556.758.4914.826.80--0.270225.851.514.23-22.14-6.7115.6612.32
Surgical Science Sweden AB61.63m13.86m519.39m270.0037.481.6328.798.433.793.7916.8587.190.17691.566.803,307,035.003.984.494.214.7868.6570.0622.4923.753.73--0.000.0010.0168.1424.47--38.57--
Medartis Holding AG196.92m3.60m593.70m829.00158.192.4325.963.010.30880.308817.0420.070.53770.56744.96265,720.500.98450.19191.130.215380.5382.331.830.35423.154.030.32270.0015.9611.81110.70-31.825.37--
Arjo AB (publ)801.55m36.63m601.56m6.85k17.601.145.610.75051.881.8841.0528.870.71494.546.781,644,896.003.263.554.625.5543.6444.014.565.410.6263.970.407343.0110.035.976.9010.15-8.8910.35
Revenio Group Oyj85.07m15.84m603.50m230.0037.677.1329.867.090.72040.72043.863.810.78344.938.17472,574.1014.6714.3317.0917.9049.2950.7318.7221.131.5134.570.127655.81-0.412525.80-12.1518.7217.676.30
Paul Hartmann AG1.99bn49.61m631.19m10.05k12.650.66624.500.317816.7616.76671.22318.251.181.995.45234,407.103.193.874.195.3458.0056.712.702.981.317.680.208242.751.802.12-21.37-18.495.952.71
Data as of Nov 21 2024. Currency figures normalised to Advanced Medical Solutions Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

46.92%Per cent of shares held by top holders
HolderShares% Held
Octopus Investments Ltd.as of 30 Oct 202428.47m13.08%
Canaccord Genuity Wealth Ltd.as of 28 Mar 202416.43m7.55%
Investec Wealth & Investment Ltd.as of 28 Mar 202413.11m6.02%
Charles Stanley & Co. Ltd.as of 28 Mar 202410.16m4.66%
Invesco Asset Management Ltd.as of 28 Mar 20248.69m3.99%
Rathbones Investment Management Ltd.as of 21 Sep 20237.17m3.29%
AXA Investment Managers UK Ltd.as of 28 Mar 20246.55m3.01%
BlackRock Fund Advisorsas of 01 Nov 20243.89m1.79%
Evelyn Partners Investment Management LLPas of 01 Nov 20243.88m1.78%
Quilter Cheviot Ltd.as of 01 Nov 20243.82m1.76%
More ▼
Data from 30 Sep 2024 - 01 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.